Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Office of Policy

Executive Summary

AdvaMed Exec VP Carol Kelly will join the Centers for Medicare & Medicaid Services to head a newly formed Office of Policy June 13. Kelly will lead a staff drawn from CMS' current Planning & Policy Analysis Group within the Office of Research, Development & Information. ORDI's Mary Ellen Stahlman will be assistant director of the office. Kelly joined AdvaMed in 1999; she previously worked at CMS (formerly known as HCFA) from 1982-1986...

You may also be interested in...



AdvaMed adds HHS health policy adviser

Ann-Marie Lynch joins AdvaMed as exec VP-payment and healthcare delivery, bringing more than 15 years of health care policy experience to the post, the device trade group reports. Lynch served most recently as principal deputy assistant secretary in the HHS Office of the Assistant Secretary for Planning & Evaluation. She will join AdvaMed Oct. 24, succeeding exec VP Carol Kelly, who left the association in June to become director of CMS' new Office of Policy (1"The Pink Sheet" May 30, 2005, In Brief)....

Coronavirus Update: US Public Confidence In COVID-19 Vaccines Declines

Confidence in the vaccine has slipped in the US, regardless of political affiliation.

Get Real: Orbital’s Chris Bunniss On Real World Evidence’s Potential For OTC Innovation

Can "real world evidence" drive consumer health innovation? HBW Insight speaks to Orbital Research’s Chris Bunniss about RWE’s potential for the OTC industry.

Topics

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel